Levy, J. H., Weitz, J. I., Bernstein, R. A., Eikelboom, J., Hylek, E., Huisman, M. V., … Pollack, C. V. (2016). Letter to the Editor: Managing Dabigatran-Related Bleeding. J Intensive Care Med, 31(1), 70–71. https://doi.org/10.1177/0885066614542758

Levy, Jerrold H., Jeffrey I. Weitz, Richard A. Bernstein, John Eikelboom, Elaine Hylek, Menno V. Huisman, Paul A. Reilly, et al. “Letter to the Editor: Managing Dabigatran-Related Bleeding.” J Intensive Care Med 31, no. 1 (January 2016): 70–71. https://doi.org/10.1177/0885066614542758.

Levy JH, Weitz JI, Bernstein RA, Eikelboom J, Hylek E, Huisman MV, et al. Letter to the Editor: Managing Dabigatran-Related Bleeding. J Intensive Care Med. 2016 Jan;31(1):70–1.

Levy, Jerrold H., et al. “Letter to the Editor: Managing Dabigatran-Related Bleeding.” J Intensive Care Med, vol. 31, no. 1, Jan. 2016, pp. 70–71. Pubmed, doi:10.1177/0885066614542758.

Levy JH, Weitz JI, Bernstein RA, Eikelboom J, Hylek E, Huisman MV, Reilly PA, Steiner T, Kamphuisen P, Kam C-W, Pollack CV. Letter to the Editor: Managing Dabigatran-Related Bleeding. J Intensive Care Med. 2016 Jan;31(1):70–71.